BAUSCH & LOMB INC

Bausch & Lomb Inc. has long been a stalwart in vision care, supplying contact lenses, lens care solutions, ophthalmic pharmaceuticals, and surgical instruments to eye care professionals, optometrists, ophthalmologists, and consumers who rely on its research-backed products to treat and prevent a range of ocular conditions; structured around its proprietary technologies and global manufacturing footprint, the company’s offerings are shaped by the Optical Goods (SIC 3851) and Medical Instruments (SIC 3841) landscape, where regulatory scrutiny on product safety, quality control, and import compliance remains intense, and where any disruption to supply chains or adverse outcomes could materially affect its reputation and results, particularly given ongoing FDA oversight and evolving international standards; as investors consider the outlook, they should note CIK 10427 and the fact that the latest filing status is currently unknown, and then view live SEC filings on Earnings Feed.

Source: Earnings Feed research · last updated 11/24/2025